Zobrazeno 1 - 10
of 523
pro vyhledávání: '"Henning Beck-Nielsen"'
Autor:
Eva M. Gram-Kampmann, Thomas B. Olesen, Camilla D. Hansen, Mie B. Hugger, Jane M. Jensen, Aase Handberg, Henning Beck-Nielsen, Aleksander Krag, Michael H. Olsen, Kurt Højlund
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-10 (2023)
Abstract Background While a low-carbohydrate diet (LCD) reduces HbA1c in patients with type 2 diabetes (T2D), the associated high intake of fat may adversely affect cardiovascular risk factors. To address this, we examined the effect of a non-calorie
Externí odkaz:
https://doaj.org/article/cbcd03ca40224f4e9d587b496b61bcd5
Autor:
Anne Cathrine Baun Thuesen, Rasmus Tanderup Jensen, Henrik Maagensen, Maja Refshauge Kristiansen, Henrik Toft Sørensen, Allan Vaag, Henning Beck-Nielsen, Oluf B. Pedersen, Niels Grarup, Jens Steen Nielsen, Jørgen Rungby, Anette Prior Gjesing, Heidi Storgaard, Tina Vilsbøll, Torben Hansen
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 35, Iss , Pp 100972- (2023)
Background: Functionally disruptive variants in the glucokinase gene (GCK) cause a form of mild non-progressive hyperglycemia, which does not require pharmacological treatment. A substantial proportion of patients with type 2 diabetes (T2D) carry GCK
Externí odkaz:
https://doaj.org/article/1696d215ff0246ea81cfebf50fdc833b
Autor:
Torben Hansen, Henrik T Sørensen, Allan Vaag, Reimar W Thomsen, Ivan Brandslund, Henning Beck-Nielsen, Emma Ahlqvist, Jens Steen Nielsen, Charlotte Brøns, Diana Hedevang Christensen, Jørgen Rungby, Peter Vestergaard, Niels Jessen, Michael H Olsen, Sia K Nicolaisen, Jacob V Stidsen, Kurt Hojlund, Sonia García-Calzón, Charlotte Ling
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 10, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/ace3725727b64bbb8a7b40d050374654
Autor:
Rikke Mette Agesen, Amra Ciric Alibegovic, Henrik Ullits Andersen, Henning Beck-Nielsen, Peter Gustenhoff, Troels Krarup Hansen, Christoffer Hedetoft, Tonny Jensen, Claus Bogh Juhl, Susanne Søgaard Lerche, Kirsten Nørgaard, Hans-Henrik Parving, Lise Tarnow, Birger Thorsteinsson, Ulrik Pedersen-Bjergaard
Publikováno v:
BMC Endocrine Disorders, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Hypoglycaemia, especially nocturnal, remains the main limiting factor of achieving good glycaemic control in type 1 diabetes. The effect of first generation long-acting insulin analogues in reducing nocturnal hypoglycaemia is well
Externí odkaz:
https://doaj.org/article/56c340efa21f4ca096ea9c50af1669e9
Autor:
Rugivan Sabaratnam, Vibe Skov, Søren K. Paulsen, Stine Juhl, Rikke Kruse, Thea Hansen, Cecilie Halkier, Jonas M. Kristensen, Birgitte F. Vind, Bjørn Richelsen, Steen Knudsen, Jesper Dahlgaard, Henning Beck-Nielsen, Torben A. Kruse, Kurt Højlund
Publikováno v:
Cells, Vol 11, Iss 13, p 2005 (2022)
Insulin resistance in skeletal muscle in type 2 diabetes (T2D) is characterized by more pronounced metabolic and molecular defects than in obesity per se. There is increasing evidence that adipose tissue dysfunction contributes to obesity-induced ins
Externí odkaz:
https://doaj.org/article/e04e3d977f274c32a863d4ccb0166e8b
Autor:
Stine Byberg, Camilla Bundesen, Frauke Rudolf, Thorny Linda Haraldsdottir, Lamine Indjai, Rui Barai, Henning Beck-Nielsen, Morten Sodemann, Dorte Møller Jensen, Morten Bjerregaard-Andersen
Publikováno v:
Global Health Action, Vol 13, Iss 1 (2020)
Background The burden of diabetes mellitus in Sub-Saharan Africa is growing rapidly, and yet the prevalence and patient characteristics are still largely unknown. Objectives We analyzed clinical and demographic characteristics of Type 2 diabetes (T2D
Externí odkaz:
https://doaj.org/article/4d888cb39b4b4396bc14e2192a121d9b
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 3, Iss 3, Pp n/a-n/a (2020)
Abstract Introduction Emerging adults (18‐30 years) with type 1 diabetes must manage a demanding chronic illness as well as navigate a life phase full of instability and transitions. Clinical care for this age group remains a challenge. An improved
Externí odkaz:
https://doaj.org/article/cc1a049617f14192a107a8b302e60f98
Publikováno v:
Biochemistry and Biophysics Reports, Vol 9, Iss C, Pp 47-50 (2017)
Carnitine acetyltransferase (CRAT) deficiency has previously been shown to result in muscle insulin resistance due to accumulation of long-chain acylcarnitines. However, differences in the acylcarnitine profile and/or changes in gene expression and p
Externí odkaz:
https://doaj.org/article/0155e8df4c794168950d4d1770a7744c
Autor:
Marianne Geilswijk, Lise Lotte Andersen, Morten Frost, Klaus Brusgaard, Henning Beck-Nielsen, Anja Lisbeth Frederiksen, Dorte Møller Jensen
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2017)
Hypoglycemia during pregnancy can have serious health implications for both mother and fetus. Although not generally recommended in pregnancy, synthetic somatostatin analogues are used for the management of blood glucose levels in expectant hyperin
Externí odkaz:
https://doaj.org/article/3832ca5acaf643d1b4a54b4b4f362b0e
Autor:
Julie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic, Henrik Ullits Andersen, Henning Beck-Nielsen, Peter Gustenhoff, Troels Krarup Hansen, Christoffer Georg Riber Hedetoft, Tonny Joran Jensen, Charlotte Røn Stolberg, Claus Bogh Juhl, Susanne Søgaard Lerche, Kirsten Nørgaard, Hans-Henrik Parving, Lise Tarnow, Birger Thorsteinsson, Ulrik Pedersen-Bjergaard
Publikováno v:
Brøsen, J M B, Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C G R, Jensen, T J, Stolberg, C R, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2022, ' Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia ', Diabetes Technology & Therapeutics, vol. 24, no. 9, pp. 643-654 . https://doi.org/10.1089/dia.2021.0567
Brøsen, J M B, Agesen, R M, Alibegovic, A C, Ullits Andersen, H, Beck-Nielsen, H, Gustenhoff, P, Krarup Hansen, T, Hedetoft, C G R, Jensen, T J, Stolberg, C R, Bogh Juhl, C, Lerche, S S, Nørgaard, K, Parving, H H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2022, ' Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia ', Diabetes Technology & Therapeutics, vol. 24, no. 9, pp. 643-654 . https://doi.org/10.1089/dia.2021.0567
Brøsen, J M B, Agesen, R M, Alibegovic, A C, Ullits Andersen, H, Beck-Nielsen, H, Gustenhoff, P, Krarup Hansen, T, Hedetoft, C G R, Jensen, T J, Stolberg, C R, Bogh Juhl, C, Lerche, S S, Nørgaard, K, Parving, H H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2022, ' Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia ', Diabetes Technology & Therapeutics, vol. 24, no. 9, pp. 643-654 . https://doi.org/10.1089/dia.2021.0567
Background and Aims: Nocturnal hypoglycemia is mainly a consequence of inappropriate basal insulin therapy in type 1 diabetes (T1D) and may compromise optimal glycemic control. Insulin degludec is associated with a lower risk of nocturnal hypoglycemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83477b07b58cfa9237757d8626ffbdc9
https://doi.org/10.1089/dia.2021.0567
https://doi.org/10.1089/dia.2021.0567